natgillin/translations-raw huggingface dataset:
In healthy subjects, co-administration of a single dose of 800 mg sonidegib with rifampicin (600 mg daily for 14 days), a strong CYP3A inducer, resulted in 72% and 54% decreases in sonidegib AUC and Cmax respectively, compared with when sonidegib was given alone. 
Zdravila, ki lahko znižajo koncentracijo sonidegiba v plazmi Pri zdravih osebah je sočasno odmerjanje enkratnega odmerka 800 mg sonidegiba skupaj z rifampicinom, ki je močan induktor CYP3A, osebe pa so ga prejemale 14 dni 600 mg enkrat na dan, povzročilo zmanjšanje
Musculoskeletal and connective tissue disorders Muscle spasms 
Bolezni mišično-skeletnega sistema in vezivnega tkiva mišični spazmi zelo pogosti mišičnoskeletne bolečine zelo pogosti mialgija zelo pogosti miopatija pogosti
Among adverse drug reactions reported (Table 2), the frequency was greater in patients taking Odomzo 800 mg than in patients taking Odomzo 200 mg except for musculoskeletal pain, diarrhoea, abdominal pain, headache and pruritus. 
Med neželenimi učinki, o katerih so poročali (preglednica 2), je bila pogostnost večja pri bolnikih, ki so prejemali zdravilo Odomzo v odmerku 800 mg, kot pri tistih, ki so prejemali zdravilo Odomzo v odmerku
MARKETING AUTHORISATION HOLDER Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87 
IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM Sun Pharmaceutical Industries Europe B.V.
A population pharmacokinetic analysis found that mild or moderate renal impairment did not have a significant effect on the apparent clearance (CL/F) of sonidegib, suggesting that dose adjustment is not necessary in patients with renal impairment (see section 5.2). 
Rezultati populacijske farmakokinetične analize kažejo, da blaga ali zmerna okvara ledvic ne vpliva bistveno na navidezni očistek
You must stop taking Odomzo and talk to your doctor immediately if you become pregnant or suspect you could be pregnant. 
Če zanosite ali sumite, da ste noseči, morate takoj prekiniti zdravljenje z zdravilom Odomzo in obvestiti zdravnika.
The Cmax and AUCinf of sonidegib in Japanese healthy subjects were 1.56 and 1.68-fold higher, respectively, than those seen in Western healthy subjects for a single dose of 200 mg. 
Vpliv rasne pripadnosti Pri zdravih Japoncih je bila po odmerjanju enkratnega odmerka 200 mg Cmax 1,56-krat višja, AUCinf pa
Ελλάδα 
• izpuščaj
The patient educational material for Odomzo should contain the following key elements: 
• poročanje o neželenih učinkih Izobraževalno gradivo za bolnike za zdravilo Odomzo mora vsebovati naslednje ključne elemente:
Cr: creatinine; ULN: upper limit of normal 
ZMN: zgornja meja normalnih vrednosti Druge spremembe odmerjanja
• That the patient should not breastfeed during treatment and for 20 months after their final dose 
• ne sme zanositi v času zdravljenja z zdravilom Odomzo in še 20 mesecev po zadnjem odmerku,
• Tubal sterilisation 
• sterilizacija z ligacijo jajcevodov
BATCH NUMBER Lot 
United Kingdom Ranbaxy UK Ltd
- You should not donate blood while on treatment with Odomzo and for 20 months after ending your treatment. 
- V času zdravljenja z zdravilom Odomzo in še 20 mesecev po zaključku zdravljenja ne smete darovati krvi.
It is an anti-cancer medicine. 
Zdravilo Odomzo vsebuje zdravilno učinkovino sonidegib in je zdravilo proti raku.
UNIQUE IDENTIFIER - 2D BARCODE 
EDINSTVENA OZNAKA - DVODIMENZIONALNA ČRTNA KODA Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako 18.
How Odomzo works 
Kako deluje zdravilo Odomzo
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET
NAME OF THE MEDICINAL PRODUCT Odomzo 200 mg hard capsules 
Odomzo 200 mg trde kapsule
Tabulated list of adverse drug reactions 
Tabelaričen prikaz neželenih učinkov
• your periods stop 
• zaprtje
• medicines such as statins and fibric acid derivatives used to treat high cholesterol and lipids 
Še posebno pomembno je, da svojemu zdravniku poveste, če jemljete katero od naslednjih zdravil: • zdravila kot so statini in derivati fibrične kisline, ki jih uporabljamo za zniževanje previsoke ravni holesterola in lipidov,
Capsule content 
Tumorski odziv na MR
Tell your doctor or pharmacist straight away if you notice any of the following: 
Če opazite katerega od naslednjih neželenih učinkov, takoj obvestite zdravnika ali farmacevta:
What Odomzo is 
Kaj je zdravilo Odomzo
Other dose modifications 
DRUGI PODATKI
• dark urine, decreased urine output or no urine output. 
• temno obarvan urin, zmanjšano ali povsem ustavljeno izločanje urina: to so lahko znaki razpadanja mišičnih vlaken, kar lahko poškoduje ledvice.
Cases of cuSCC have been reported in advanced BCC patients treated with Odomzo. 
Pri bolnikih z napredovalim bazalnoceličnim karcinomom, ki so prejemali zdravilo Odomzo, so poročali o primerih ploščatoceličnega karcinoma kože.
This difference was not statistically significant. 
Razlika ni bila statistično pomembna.
They usually affect the face and mouth first but can affect other parts of the body. 
Ponavadi najprej prizadenejo obraz in usta, lahko pa tudi druge dele telesa.
The majority were mild and improved on subsequent injections. 
Večina je bila blagih in so se pri nadaljnjih injiciranjih izboljšale.
The 518 events included 291 serious events of which 31 events were fatal. 
Teh 518 dogodkov je vključevalo 291 resnih dogodkov, od tega 31 dogodkov s smrtnim izidom.
Log-Rank Test 
Preskus Log-Rank
• dementia (loss of memory and other mental abilities) especially if you are elderly 
• demenco (izgubo spomina in drugih duševnih sposobnosti), zlasti če ste starejši,
• suicide attempt and suicide 
• poskus samomora in samomor,
Engage the needle safety device as described in Step 2 e). 
Varnostni pripomoček za iglo pritrdimo, kot je opisano v koraku 2 e).
These symptoms can temporally deteriorate or can even arise after discontinuation of treatment. 
Ti simptomi se lahko začasno poslabšajo ali se celo pojavijo po prekinitvi zdravljenja.
The US Product Information already mentions a class warning for antipsychotics since 2017. 
Informacije o zdravilih v ZDA od leta 2017 že omenjajo razredno opozorilo za antipsihotike.
Your doctor will alternate the injections between your right and left side. 
Zdravnik vam bo izmenično dajal injekcije v vašo levo in desno stran.
• reduced sexual interest (libido is decreased) 
• zmanjšano zanimanje za spolnost (zmanjšan libido),
d) Determine the recommended volume for injection. 
d) Določimo priporočeno količino za injiciranje.
This means that the medicine is essentially ‘sodium-free'. 
To pomeni, da je zdravilo v bistvu »brez natrija«.
The suspension should be injected immediately after reconstitution. 
Suspenzijo je treba injicirati takoj po rekonstituciji.
• inability to have or maintain an erection during sexual intercourse 
• nezmožnost imeti ali vzdrževati erekcijo med spolnim odnosom,
There are no adequate and well-controlled trials of aripiprazole in pregnant women. 
Ustreznih in dobro nadzorovanih preskušanj aripiprazola pri nosečnicah ni.
The medical supervision and monitoring should continue until the patient recovers. 
Zdravniški nadzor in spremljanje je treba nadeljevati, vse dokler si bolnik ne opomore.
Avoid use 
Izogibajte se uporabi
In this section, there is no mention of eye movement disorders. 
V tem poglavju ni omenjenih motenj gibanja oči.
Consequently, new-born infants should be monitored carefully (see section 4.8). 
Zato je treba novorojenčke pozorno spremljati (glejte poglavje 4.8).
a Data were analysed using a mixed model repeated measures (MMRM) approach. 
a Podatke so analizirali s pristopom mešanega modela ponovljivih meritev (MMRM).
Date of first authorisation: 15 November 2013 Date of latest renewal: 27 August 2018 
Datum prve odobritve: 15. november 2013 Datum zadnjega podaljšanja:
Tell your doctor if you experience any of these behaviours; he/she will discuss ways of managing or reducing the symptoms. 
Obvestite svojega zdravnika, če opazite katero od navedenih vedenjskih sprememb; z vami se bo pogovoril o načinih obvladovanja ali zmanjšanja simptomov.
(including so called QT prolongation seen with ECG monitoring). 
(vključno s tako imenovanim podaljšanjem intervala QT, ki ga opazimo pri spremljanju EKG),
Patients should be closely monitored throughout this period. 
Bolnike je treba ves čas skrbno spremljati.
• medicines that are known to prolong QT prolongation. 
• zdravila, za katera je znano, da podaljšajo interval QT.
Numbers of Subjects at Risk 
Število oseb s tveganjem
- if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na aripiprazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Fall: Although the available data did not provide sufficient evidence to support a clear causal relationship between aripiprazole and this ADR, 507 cases have been identified reporting 518 events of Fall associated with Abilify. 
Padci: Čeprav razpoložljivi podatki niso zagotovili zadostnih dokazov v podporo jasni vzročni povezavi med aripiprazolom in tem neželenim učinkom, je bilo ugotovljenih 507 primerov, ki so poročali o 518 dogodkih padcev, povezanih z zdravilom Abilify.
• gastroesophageal reflux disease. 
• gastroezofagealna refluksna bolezen.
e) Subsequently, remove the needle from the vial. 
e) Nato iglo odstranite iz viale.
You may feel a little pain during the injection. 
Med injiciranjem lahko začutite rahlo bolečino.
These could be signs of a condition called “tardive dyskinesia”. 
To so lahko znaki stanja, imenovanega »tardivna diskinezija«;
The PSP is a validated clinician-rated scale that measures personal and social functioning in four domains: socially useful activities (e.g. work and study), personal and social relationships, self-care, and disturbing and aggressive behaviours. 
PSP je validirana lestvica, ki jo izpolni zdravnik, za merjenje osebnega in socialnega funkcioniranja na štirih področjih: socialno uporabne dejavnosti (npr. delo in študij), osebni in socialni odnosi, skrb zase ter moteče in agresivno vedenje.
The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known (frequency cannot be estimated from the available data): 
Po trženju peroralnega aripiprazola so poročali o naslednjih neželenih učinkih, vendar njihova pogostnost ni znana (pogostnosti ni mogoče oceniti iz razpoložljivih podatkov):
• unable to keep still, difficulty sitting still 
• nezmožnost biti pri miru, nezmožnost sedeti pri miru,
In this context, and given the seriousness of the consequences of falls, especially in elderly, the PRAC believes that an update of the Product Information with inclusion of a warning in section 4.4 of the SmPC is recommended. 
Glede na to in na resnost posledic padcev, zlasti pri starejših, odbor PRAC meni, da je priporočilo o posodobitvi Informacij o zdravilu z vključitvijo opozorila v poglavju 4.4 Povzetka glavnih značilnosti zdravila utemeljeno.
• unusual movement mainly of the face or tongue, since your doctor may want to lower your dose. 
• neobičajne gibe, posebej v mišicah obraza ali jezika, saj bo morda vaš zdravnik želel zmanjšati odmerek;
There are a further 154 cumulative spontaneous reports of eye movement disorder, of which 22 were serious. 
Obstaja še skupaj 154 spontanih poročil o motnjah gibanja oči, od katerih je bilo
The injections will not be given intravenously. 
Injekcije se ne daje intravensko.
• high blood sugar 
• visok krvni sladkor,
The recommended and starting dose is 400 mg unless your doctor decided to give you a lower starting or follow up dose (300 mg, 200 mg or 160 mg). 
Priporočeni začetni odmerek je 400 mg, razen če se zdravnik odloči, da vam bo dal manjši odmerek ob začetku zdravljenja ali ob spremljevalnem obisku (300 mg, 200 mg ali 160 mg).
P-value Treatment differenceb (95 % CI) 
Razlika pri zdravljenjub (95-odstotni IZ)
Tell your doctor if you are taking, have recently taken or might take any other medicines. 
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali boste morda začeli jemati katero koli drugo zdravilo.
Step 5: Procedures after injection 
Korak 5: Postopki po injiciranju
The 95 % CI (-5.26, 3.99) for the difference in the estimated proportion of patients experiencing impending relapse by end of Week 26 excluded the predefined non-inferiority margin, 11.5 %. 
95 % IZ (-5,26, 3,99) za razliko v ocenjenem razmerju bolnikov, pri katerih se do konca 26. tedna pojavijo znaki bližnjega relapsa bolezni, izključuje predhodno opredeljeno mejo neinferiornosti, ki znaša 11,5 %.
• kidney stones, sugar (glucose) in urine 
• ledvični kamni, sladkor (glukoza) v urinu,
The safety and efficacy of Abilify Maintena in children and adolescents aged 0-17 years have not been established. 
Varnost in učinkovitost zdravila Abilify Maintena pri otrocih in mladostnikih, starih od 0 do 17 let, še nista bili dokazani.
• difficulty sleeping (insomnia) 
• težave s spanjem (nespečnost),
Less than 1 % of unchanged aripiprazole was excreted in the urine and approximately 18 % was recovered unchanged in the faeces. 
aripiprazola se je nespremenjenega izločilo v urinu in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
The highest non-tumorigenic exposure in female rats was approximately 7 times the human exposure at the recommended dose. 
Največja netumorogena izpostavljenost samic podgan je bila 7-krat večja od izpostavljenosti človeka pri priporočenem odmerku.
• loss of strength 
• izguba moči,
Personal and social functioning were evaluated using the Personal and Social Performance (PSP) scale. 
Z lestvico osebne in socialne odličnosti (PSP) so ocenili osebno in socialno funkcioniranje.
Blood pressure-lowering medicines: Abilify Maintena may increase the effect of medicines used to lower the blood pressure. 
Zdravila za zniževanje visokega krvnega tlaka: zdravilo Abilify Maintena lahko poveča učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
• akathisia (an uncomfortable feeling of inner restlessness and a compelling need to move constantly) 
• akatizija (neprijeten občutek notranjega nemiru in nujna potreba po nenehnem gibanju),
The table is based on adverse reactions reported during clinical trials and/or post-marketing use. 
Preglednica temelji na neželenih učinkih, o katerih so poročali med kliničnimi preskušanji in/ali med uporabo v obdobju trženja.
You should be given an injection every month but not before the 26 days has passed from the last injection. 
Injekcijo bi morali prejeti vsak mesec, vendar ne prej kot 26 dni po zadnjem injiciranju.
Three hypodermic safety needles 
Tri hipodermične varnostne igle
It should be noted that impulse-control symptoms can be associated with the underlying disorder; however, in some cases, urges were reported to have stopped when the dose was reduced or the medicinal productation was discontinued. 
Upoštevati je treba, da je lahko motnja nadzora impulzov povezana z osnovno boleznijo, vendar so v nekaterih primerih poročali, da so impulzi izzveneli po zmanjšanju odmerka ali ukinitvi zdravila.
Look for signs or symptoms of inadvertent intravenous administration. 
Bodite pozorni na znake ali simptome nenamernega intravenskega vbrizganja.
• dizziness when getting up from a lying or sitting position due to a drop in blood pressure 
• omotičnost pri vstajanju iz ležečega ali sedeča položaja zaradi padca krvnega tlaka,
Interaction with receptors other than dopamine and serotonin subtypes may explain some of the other clinical effects of aripiprazole. 
Medsebojni vpliv z drugimi receptorji, razen dopaminskih in serotoninskih podvrst, lahko razloži nekatere druge klinične učinke aripiprazola.
At therapeutic concentrations, aripiprazole and dehydro-aripiprazole are greater than 99 % bound to serum proteins, binding primarily to albumin. 
terapevtskih koncentracijah sta aripiprazol in dehidroaripiprazol več kot 99 % vezana na beljakovine v serumu, predvsem na albumin.
Your doctor will make it into a suspension that will be given as an injection. 
Vaš zdravnik ju bo uporabil za pripravo suspenzije, ki bo dana z injiciranjem.
All the other formulations only state in section 4.8 that dystonia is a class effect of this medication. 
Za vse druge farmacevtske oblike je v poglavju 4.8 navedeno le, da je distonija neželeni učinek te skupine zdravil.
These effects gradually resolved with discontinuation of dosing. 
Ti učinki so postopoma izzveneli po prekinitvi odmerjanja.
If you notice any of these symptoms seek medical advice immediately. 
Če opazite katerega od teh simptomov, takoj poiščite zdravniško pomoč;
In addition, reports of accidental overdose with aripiprazole alone (up to 195 mg) in children have been received with no fatalities. 
Opisani so tudi primeri naključnega prevelikega odmerjanja aripiprazola samega (do 195 mg) pri otrocih brez smrtnih primerov.
• fits (seizures) since your doctor may want to monitor you more closely 
• epileptične krče (konvulzije), saj bo zdravnik v tem primeru morda želel natančneje spremljati vaše stanje,
The final efficacy analysis included 403 randomised patients and 80 exacerbations of psychotic symptoms/impending relapse events. 
Končna analiza učinkovitosti je vključevala 403 randomiziranih bolnikov, pri čemer se je pri 80 bolnikih pojavilo poslabšanje psihotičnih simptomov/znaki bližnjega relapsa.
A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from aripiprazole therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. 
Odločiti se je treba med prenehanjem dojenja in prenehanjem/prekinitvijo zdravljenja z aripiprazolom, pri čemer je treba upoštevati prednosti dojenja za otroka in prednosti zdravljenja za mater.
During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks. 
Do izboljšanja bolnikovega kliničnega stanja med antipsihotičnim zdravljenjem lahko mine od nekaj dni do več tednov.
Days from Randomization 
Število dni od randomizacije
• difficulty controlling core body temperature or overheating 
• težave z uravnavanjem jedrne telesne temperature ali pregrevanjem,
Step 4: Procedures after injection 
Korak 4: Postopki po injiciranju
While these symptoms can occur at low doses, they occur more frequently and with greater severity with high potency and at higher doses of first generation antipsychotic medicinal products. 
Ti simptomi se sicer lahko pojavijo že pri majhnih odmerkih, njihova pogostnost in resnost pa naraščata z močjo in z uporabo večjih odmerkov antipsihotikov prve generacije.
In patients who are known to be CYP2D6 poor metabolisers, the starting and maintenance dose should be 300 mg. 
Pri bolnikih, za katere je znano, da slabo presnavljajo s CYP2D6, mora biti začetni in vzdrževalni odmerek 300 mg.
The injection should be administered as soon as possible and then the monthly injection schedule should be resumed. 
Injekcijo je treba dati čimprej in nadaljevati z mesečnim režimom injiciranja.
They may be caused by an abnormal muscle breakdown which can be life threatening and lead to kidney problems (a condition called rhabdomyolysis) 
Lahko jih povzroči nenormalna razgradnja mišic, ki lahko ogroža življenje in povzroči težave z ledvicami (stanje, imenovano rabdomioliza),
Risk factors that may predispose patients to severe complications include obesity and family history of diabetes. 
Med dejavniki tveganja, ki lahko povečajo bolnikovo nagnjenost k hudim zapletom, so debelost in družinska anamneza sladkorne bolezni.
deltoid gluteal 
deltoidna glutealna
• heart problems or have a history of stroke, especially if you know that you have other risks factors for stroke 
• težave s srcem ali anamneza možganske kapi, zlasti če veste, da imate druge dejavnike tveganja za možgansko kap,
Chemical and physical in-use stability has been demonstrated for 4 hours at 25 °C. 
Zdravilo je med uporabo kemično in fizikalno stabilno 4 ure pri temperaturi 25 °C.
Oculogyric crisis: From post-marketing sources, there were 20 reports of oculogyric crisis during the interval (11 serious) and 244 reports cumulatively (92 serious). 
Okulogirna kriza: Viri v obdobju trženja so v intervalu podali 20 poročil o okulogirni krizi (11 resnih) in skupaj 244 poročil (92 resnih).
• irregular heart beat or if someone else in your family has a history of irregular heart beat 
• nepravilni srčni ritem ali če ima kdo drug v vaši družini anamnezo nepravilnega srčnega ritma
• weakness, loss of strength or extreme tiredness 
• šibkost, izguba moči ali huda utrujenost,
• muscle weakness, tenderness or pain and particularly, if at the same time, you feel unwell, have a high temperature or have dark urine. 
• mišična oslabelost, občutljivost ali bolečina in še posebej, če se pojavita sočasno, se slabo počutite, imate visoko telesno temperaturo ali imate temen urin.
For all other aripiprazole products, oculogyric crisis is not listed. 
Za vsa druga zdravila z aripiprazolom okulogirna kriza ni navedena.
Nevertheless, there were differences from what has been observed with maintenance use in the treatment of schizophrenia. 
Vendar so kljub temu opazili razlike glede na uporabo vzdrževalnih odmerkov pri zdravljenju shizofrenije.
Given that dystonia is a well-known side effect of this drug and the large number of reported cases it seems likely that aripiprazole can cause oculogyric crisis. 
Glede na to, da je distonija dobro znan neželeni učinek tega zdravila in da obstaja veliko poročil o primerih, se zdi verjetno, da lahko aripiprazol povzroči okulogirno krizo.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before receiving this medicine. 
Nosečnost, dojenje in plodnost Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom, preden prejmete to zdravilo.
For oral aripiprazole, toxicologically significant effects were observed only at doses or exposures that were sufficiently in excess of the maximum human dose or exposure, indicating that these effects were limited or of no relevance to clinical use. 
Za peroralni aripiprazol so toksikološko pomembne učinke opazili samo pri odmerkih ali izpostavljenosti, ki so močno presegali največje odmerke ali izpostavljenost pri človeku; to kaže, da so ti učinki za klinično uporabo le omejenega pomena ali celo nepomembni.
From a microbiological point of view, unless the method of opening/ reconstitution precludes the risk of microbial contamination, the product should be used immediately. 
Iz mikrobiološkega vidika je treba zdravilo uporabiti takoj, razen kadar način odpiranja/rekonstitucije preprečuje tveganje onesnaženja zdravila z mikrobi.
Patients must be advised to notify their physician if they become pregnant or intend to become pregnant during treatment with aripiprazole. 
Bolnicam je treba svetovati, da morajo obvestiti svojega zdravnika, če med zdravljenjem z aripiprazolom zanosijo ali nameravajo zanositi.
Do not inject into an area with signs of inflammation, skin damage, lumps and/or bruises. 
Ne injicirajte na mestu, kjer so znaki vnetja, poškodbe kože, zatrdline in/ali odrgnine.
H. Lundbeck A/S Ottiliavej 9, 2500 Valby Denmark 
H. Lundbeck A/S Ottiliavej 9, 2500 Valby Danska
Be sure to tell your doctor immediately if you are pregnant, think you may be pregnant, or if you are planning to become pregnant. 
Zdravniku morate takoj povedati, če ste noseči oziroma mislite, da ste zanosili, ali če nameravate zanositi.
In three placebo-controlled trials of oral aripiprazole in elderly patients with psychosis associated with Alzheimer's disease (n = 938; mean age: 82.4 years; range: 56-99 years), patients treated with aripiprazole were at an increased risk of death compared to placebo. 
V treh s placebom nadzorovanih preskušanjih peroralnega aripiprazola pri starejših bolnikih s psihozo, povezano z Alzheimerjevo boleznijo (n = 938; povprečna starost: 82,4 let; razpon: 56-99 let), je bilo tveganje smrti večje pri bolnikih, ki so dobivali aripiprazol, kot pri tistih, ki so dobivali placebo.
After plunger rod is at complete stop, middle stopper will be at the indicator line. 
Ko se potiskalo bata povsem zaustavi, bo sredinska zaporka pri črtni oznaki.